For instance, melittin can inhibit cell growth of human ovarian cancer cells increasing the expression of death receptors (DR3, DR4 and DR6) and the inactivation of the signal transducers and activators of the transcription 3 (STAT3) pathway, ending in the apoptosis of the cells [72]. This evidence concerns the gene TNFRSF10A and ovarian cancer.